Vasundhara Rasayans Ltd
Incorporated in 1987, Vasundhara Rasayans Ltd manufacturing and exporter Antacids therapeutic category of Active Pharm Ingredients
- Market Cap ₹ 70.6 Cr.
- Current Price ₹ 222
- High / Low ₹ 285 / 132
- Stock P/E 16.9
- Book Value ₹ 98.3
- Dividend Yield 0.89 %
- ROCE 28.8 %
- ROE 23.1 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.99 | 18.53 | 20.83 | 18.40 | 15.27 | 15.41 | 16.58 | 19.71 | 21.17 | 22.68 | 26.70 | 37.88 | 35.79 | |
18.62 | 16.27 | 17.27 | 16.80 | 13.97 | 13.76 | 14.78 | 18.55 | 18.33 | 19.57 | 24.49 | 32.32 | 31.09 | |
Operating Profit | -0.63 | 2.26 | 3.56 | 1.60 | 1.30 | 1.65 | 1.80 | 1.16 | 2.84 | 3.11 | 2.21 | 5.56 | 4.70 |
OPM % | -3.50% | 12.20% | 17.09% | 8.70% | 8.51% | 10.71% | 10.86% | 5.89% | 13.42% | 13.71% | 8.28% | 14.68% | 13.13% |
2.98 | 0.24 | 0.14 | 0.31 | 0.25 | 0.44 | 7.74 | 1.04 | 1.15 | 0.99 | 1.04 | 2.30 | 1.36 | |
Interest | 0.82 | 0.76 | 0.64 | 0.53 | 0.57 | 0.39 | 0.17 | 0.08 | 0.06 | 0.09 | 0.09 | 0.25 | 0.30 |
Depreciation | 0.89 | 0.92 | 0.92 | 0.50 | 0.56 | 0.56 | 0.32 | 0.05 | 0.03 | 0.05 | 0.12 | 0.13 | 0.22 |
Profit before tax | 0.64 | 0.82 | 2.14 | 0.88 | 0.42 | 1.14 | 9.05 | 2.07 | 3.90 | 3.96 | 3.04 | 7.48 | 5.54 |
Tax % | 31.25% | 41.46% | 34.11% | 34.09% | 45.24% | 59.65% | 28.07% | 29.95% | 23.59% | 25.76% | 28.62% | 25.27% | |
0.44 | 0.48 | 1.41 | 0.58 | 0.24 | 0.46 | 6.52 | 1.45 | 2.99 | 2.94 | 2.17 | 5.59 | 4.16 | |
EPS in Rs | 1.38 | 1.51 | 4.44 | 1.82 | 0.76 | 1.45 | 20.51 | 4.56 | 9.41 | 9.25 | 6.83 | 17.59 | 13.08 |
Dividend Payout % | 36.14% | 33.12% | 11.28% | 27.41% | 0.00% | 69.13% | 4.88% | 21.93% | 15.95% | 16.22% | 14.65% | 11.38% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 18% |
3 Years: | 21% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | 28% |
5 Years: | 27% |
3 Years: | 24% |
TTM: | -37% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 43% |
3 Years: | 39% |
1 Year: | 36% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 16% |
Last Year: | 23% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 |
Reserves | 1.81 | 2.11 | 3.33 | 3.72 | 3.96 | 4.04 | 10.56 | 11.63 | 14.23 | 16.69 | 18.36 | 23.64 | 28.05 |
6.90 | 6.54 | 4.44 | 5.58 | 5.01 | 3.10 | 1.41 | 0.46 | 0.00 | 0.00 | 1.31 | 4.02 | 1.18 | |
3.33 | 3.37 | 3.47 | 4.16 | 3.21 | 3.13 | 5.23 | 5.56 | 7.28 | 3.14 | 2.66 | 3.68 | 5.66 | |
Total Liabilities | 15.22 | 15.20 | 14.42 | 16.64 | 15.36 | 13.45 | 20.38 | 20.83 | 24.69 | 23.01 | 25.51 | 34.52 | 38.07 |
7.09 | 6.53 | 5.79 | 7.62 | 7.28 | 6.78 | 0.10 | 0.20 | 0.30 | 0.67 | 0.91 | 0.86 | 2.54 | |
CWIP | 0.00 | 0.00 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.27 | 0.18 | 0.18 | 0.23 | 0.18 | 0.07 | 1.10 | 1.23 | 0.97 | 1.12 | 0.32 | 0.00 | 0.64 |
7.86 | 8.49 | 8.14 | 8.79 | 7.90 | 6.60 | 19.18 | 19.40 | 23.42 | 21.22 | 24.28 | 33.66 | 34.89 | |
Total Assets | 15.22 | 15.20 | 14.42 | 16.64 | 15.36 | 13.45 | 20.38 | 20.83 | 24.69 | 23.01 | 25.51 | 34.52 | 38.07 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.90 | 1.65 | 3.18 | 1.56 | 1.32 | 2.42 | -10.70 | 0.43 | 0.36 | 0.22 | 7.90 | -6.50 | |
-0.47 | -0.18 | -0.51 | -2.02 | -0.06 | 0.07 | 13.30 | 0.53 | 1.02 | 0.16 | 1.39 | 1.27 | |
-0.54 | -1.27 | -2.88 | 0.46 | -1.28 | -2.24 | -2.26 | -1.36 | -0.87 | -0.49 | 0.79 | 2.19 | |
Net Cash Flow | -0.11 | 0.20 | -0.21 | 0.00 | -0.01 | 0.24 | 0.33 | -0.41 | 0.50 | -0.12 | 10.08 | -3.04 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 68.37 | 93.17 | 65.71 | 74.39 | 93.22 | 89.53 | 131.65 | 94.63 | 107.41 | 99.30 | 100.34 | 77.57 |
Inventory Days | 52.66 | 33.50 | 39.14 | 45.71 | 53.90 | 69.11 | 64.32 | 60.51 | 59.00 | 48.01 | 57.91 | 79.48 |
Days Payable | 46.07 | 47.96 | 42.15 | 59.78 | 31.68 | 52.91 | 62.28 | 45.28 | 59.39 | 76.61 | 57.65 | 48.68 |
Cash Conversion Cycle | 74.96 | 78.71 | 62.70 | 60.32 | 115.44 | 105.73 | 133.69 | 109.85 | 107.02 | 70.70 | 100.60 | 108.36 |
Working Capital Days | 109.97 | 101.84 | 85.16 | 98.19 | 122.38 | 88.11 | 289.71 | 254.07 | 267.41 | 143.88 | 145.73 | 213.24 |
ROCE % | 12.54% | 13.24% | 24.41% | 12.04% | 8.04% | 13.44% | 14.21% | 14.14% | 23.75% | 21.73% | 12.92% | 28.79% |
Documents
Announcements
- Submission Of Compliance Certificate As Per Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For Year Ended March 31St, 2024. 15 Apr
- Submission Of Certificate As Per Regulation 40(9) Of SEBI Listing Regulations 2015. 15 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Certificate as per Regulation 74(5) of SEBI(Depositories and participants Regulations),2018 for the quater ended 31.03.2024.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 8 Apr
-
Announcement under Regulation 30 (LODR)-Resignation of Director
4 Apr - Reg 30 of SEBI(LODR), 2015, read with of Para A of Part-A of Schedule III of SEBI(LODR), 2015, this is to inform that, Mr. Ashish …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
Company offers wide range antacid therapeutic category of API andis also having an API intermediate plant to handle organic product